Age, sex, race/ethnicity, and time-adjusted SIRs for selected cancers among patients with SCD, California, 1988-2014
| . | Observed cases . | Expected cases . | SIR . | 95% CI . |
|---|---|---|---|---|
| All cancers | 115 | 143.70 | 0.80 | (0.66-0.96) |
| Solid tumor | 76 | 123.25 | 0.62 | (0.49-0.77) |
| Breast | 16 | 29.73 | 0.54 | (0.31-0.87) |
| Respiratory | 16 | 13.13 | 1.22 | (0.70-1.98) |
| Digestive system | 16 | 22.18 | 0.72 | (0.41-1.17) |
| Urinary system | 8 | 6.06 | 1.32 | (0.57-2.60) |
| Female genital | 5 | 11.63 | 0.43 | (0.14-1.00) |
| Male genital | 6 | 16.71 | 0.36 | (0.13-0.78) |
| Hematologic tumors | 31 | 18.03 | 1.72 | (1.17-2.44) |
| Lymphoma | 15 | 10.38 | 1.45 | (0.81-2.38) |
| Leukemia | 12 | 5.17 | 2.32 | (1.20-4.05) |
| ALL | 3 | 1.64 | 1.83 | (0.38-5.35) |
| CLL | 3 | 0.62 | 4.83 | (1.00-14.11) |
| AML | 6 | 1.67 | 3.59 | (1.32-7.82) |
| . | Observed cases . | Expected cases . | SIR . | 95% CI . |
|---|---|---|---|---|
| All cancers | 115 | 143.70 | 0.80 | (0.66-0.96) |
| Solid tumor | 76 | 123.25 | 0.62 | (0.49-0.77) |
| Breast | 16 | 29.73 | 0.54 | (0.31-0.87) |
| Respiratory | 16 | 13.13 | 1.22 | (0.70-1.98) |
| Digestive system | 16 | 22.18 | 0.72 | (0.41-1.17) |
| Urinary system | 8 | 6.06 | 1.32 | (0.57-2.60) |
| Female genital | 5 | 11.63 | 0.43 | (0.14-1.00) |
| Male genital | 6 | 16.71 | 0.36 | (0.13-0.78) |
| Hematologic tumors | 31 | 18.03 | 1.72 | (1.17-2.44) |
| Lymphoma | 15 | 10.38 | 1.45 | (0.81-2.38) |
| Leukemia | 12 | 5.17 | 2.32 | (1.20-4.05) |
| ALL | 3 | 1.64 | 1.83 | (0.38-5.35) |
| CLL | 3 | 0.62 | 4.83 | (1.00-14.11) |
| AML | 6 | 1.67 | 3.59 | (1.32-7.82) |
ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia.